O-052 The pennsylvania post-market multicenter experience with flow re-direction endoluminal device (FRED)

ConclusionThe results of the early post-market experience with the FRED device show reasonable safety and adequate aneurysmal occlusion rates comparable to other flow diverters. However, more extensive multicenter studies with more extended follow-up data are needed to assess the long-term safety and durability of the device.Abstract O-052 Table 1Baseline descriptive statistics Number of patients n=61 Gender Male 11 (18%) Female 50 (82%) Age (Years: median; IQR) 58 (51 – 68) Multiple Intracranial Aneurysms 21 (34.4%) Family history of aneurysms 9 (14.8%) Smoking History Never smokers 26 (42.6%) Past smokers 13 (21.3%) Current smokers 22 (36.1%) Pretreatment mRS 0 52 (85.3%) 1–2 9 (14.7%) Comorbidities Hypertension 26 (42.6%) Hyperlipidemia 16 (26.2%) Diabetes 10 (16.4%) Coronary artery disease 4 (6.5%) Prior stroke (ischemic or hemorrhagic) 3 (4.9%) Abstract O-052 Table 2Aneurysms characteristics Treated aneurysms baseline characteristics n=72 Morphology Saccular 58 (80.5%) Fusiform 11 (15.3%) Dissecting 3 (4.2%) Location ICA 63 (87.5%) cervical (C1) 5 (6.9%) petrous (C2) 2 (2.8%) cavernous (C4) 8 (11.1%) clinoid (C5) 3 (4.2%) supraclinoid (C6) 31 (43.1%) communicating (C7) 14 (19.5%) ACA 3 (4.2%) MCA 2 (2.8%) VA 2 (2.8%) PCA 2 (2.8%) Presentation Unruptured 62 (86.1%) Ruptured (> 2 weeks) 10 (13.9%) Previous treatment Coiling 15 (20.8%) WEB embolization 1 (1.4%) Clipping 1 (1.4%) Maximal diameter, mm* 7.1 (5.2 -11.9) Small (i.e., ...
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: SNIS 19th annual meeting oral abstracts Source Type: research